Yazar "Iqbal, Nazia" seçeneğine göre listele
Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Phase 3 trial evaluating efficacy and safety of odronextamab plus CHOP vs rituximab plus CHOP in previously untreated diffuse large B-cell lymphoma (DLBCL; OLYMPIA-3).(Lippincott Williams & Wilkins, 2024) Matasar, Matthew; Turgut, Burhan; Tessoulin, Benoit; Guidez, Stephanie; Altuntas, Fevzi; Iqbal, Nazia; Namuduri, Manjusha[Abstract Not Available]
